173 related articles for article (PubMed ID: 37787025)
21. Omega-3 polyunsaturated fatty acids (n-3 PUFAs), somatic and fatigue symptoms in cardiovascular diseases comorbid major depressive disorder (MDD): A randomized controlled trial.
Chang JP; Chang SS; Chen HT; Chien YC; Yang HT; Huang SY; Tseng PT; Chang CH; Galecki P; Su KP
Brain Behav Immun; 2023 Aug; 112():125-131. PubMed ID: 37301235
[TBL] [Abstract][Full Text] [Related]
22. Omega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial.
Lin PY; Cheng C; Satyanarayanan SK; Chiu LT; Chien YC; Chuu CP; Lan TH; Su KP
Brain Behav Immun; 2022 Jan; 99():289-298. PubMed ID: 34755655
[TBL] [Abstract][Full Text] [Related]
23. The effects of a high eicosapentaenoic acid multinutrient supplement on measures of stress, anxiety and depression in young adults: Study protocol for NutriMOOD, a randomised double-blind placebo-controlled trial.
Kelaiditis CF; Gibson EL; Dyall SC
Prostaglandins Leukot Essent Fatty Acids; 2021 Oct; 173():102335. PubMed ID: 34461561
[TBL] [Abstract][Full Text] [Related]
24. Effects of stearidonic acid on serum triacylglycerol concentrations in overweight and obese subjects: a randomized controlled trial.
Pieters DJ; Mensink RP
Eur J Clin Nutr; 2015 Jan; 69(1):121-6. PubMed ID: 25226826
[TBL] [Abstract][Full Text] [Related]
25. A protocol for a randomised controlled trial investigating the effect of increasing Omega-3 index with krill oil supplementation on learning, cognition, behaviour and visual processing in typically developing adolescents.
van der Wurff IS; von Schacky C; Berge K; Kirschner PA; de Groot RH
BMJ Open; 2016 Jul; 6(7):e011790. PubMed ID: 27401364
[TBL] [Abstract][Full Text] [Related]
26. The efficacy of omega-3 supplementation for major depression: a randomized controlled trial.
Lespérance F; Frasure-Smith N; St-André E; Turecki G; Lespérance P; Wisniewski SR
J Clin Psychiatry; 2011 Aug; 72(8):1054-62. PubMed ID: 20584525
[TBL] [Abstract][Full Text] [Related]
27. The mothers, Omega-3 and mental health study.
Mozurkewich E; Chilimigras J; Klemens C; Keeton K; Allbaugh L; Hamilton S; Berman D; Vazquez D; Marcus S; Djuric Z; Vahratian A
BMC Pregnancy Childbirth; 2011 Jun; 11():46. PubMed ID: 21696635
[TBL] [Abstract][Full Text] [Related]
28. Effects of ethyl-eicosapentaenoic acid omega-3 fatty acid supplementation on hot flashes and quality of life among middle-aged women: a double-blind, placebo-controlled, randomized clinical trial.
Lucas M; Asselin G; Mérette C; Poulin MJ; Dodin S
Menopause; 2009; 16(2):357-66. PubMed ID: 19034052
[TBL] [Abstract][Full Text] [Related]
29. Omega-3 fatty acid supplementation for cystic fibrosis.
Watson H; Stackhouse C
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
[TBL] [Abstract][Full Text] [Related]
30. The differential effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on seizure frequency in patients with drug-resistant epilepsy - A randomized, double-blind, placebo-controlled trial.
Ibrahim FAS; Ghebremeskel K; Abdel-Rahman ME; Ahmed AAM; Mohmed IM; Osman G; Elseed M; Hamed A; Rabinowicz AL; Salih MAM; Elbashir MI; Daak AA
Epilepsy Behav; 2018 Oct; 87():32-38. PubMed ID: 30170260
[TBL] [Abstract][Full Text] [Related]
31. Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial.
Dangour AD; Allen E; Elbourne D; Fasey N; Fletcher AE; Hardy P; Holder GE; Knight R; Letley L; Richards M; Uauy R
Am J Clin Nutr; 2010 Jun; 91(6):1725-32. PubMed ID: 20410089
[TBL] [Abstract][Full Text] [Related]
32. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.
Carney RM; Freedland KE; Rubin EH; Rich MW; Steinmeyer BC; Harris WS
JAMA; 2009 Oct; 302(15):1651-7. PubMed ID: 19843899
[TBL] [Abstract][Full Text] [Related]
33. Comparison between the AA/EPA ratio in depressed and non depressed elderly females: omega-3 fatty acid supplementation correlates with improved symptoms but does not change immunological parameters.
Rizzo AM; Corsetto PA; Montorfano G; Opizzi A; Faliva M; Giacosa A; Ricevuti G; Pelucchi C; Berra B; Rondanelli M
Nutr J; 2012 Oct; 11():82. PubMed ID: 23046564
[TBL] [Abstract][Full Text] [Related]
34. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
[TBL] [Abstract][Full Text] [Related]
35. Supplementation of n-3 Polyunsaturated Fatty Acids for Major Depressive Disorder: A Randomized, Double-Blind, 12-Week, Placebo-Controlled Trial in Korea.
Park Y; Park YS; Kim SH; Oh DH; Park YC
Ann Nutr Metab; 2015; 66(2-3):141-148. PubMed ID: 25824637
[TBL] [Abstract][Full Text] [Related]
36. Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder.
Bos DJ; Oranje B; Veerhoek ES; Van Diepen RM; Weusten JM; Demmelmair H; Koletzko B; de Sain-van der Velden MG; Eilander A; Hoeksma M; Durston S
Neuropsychopharmacology; 2015 Sep; 40(10):2298-306. PubMed ID: 25790022
[TBL] [Abstract][Full Text] [Related]
37. Phase II prospective randomized trial of a low-fat diet with fish oil supplementation in men undergoing radical prostatectomy.
Aronson WJ; Kobayashi N; Barnard RJ; Henning S; Huang M; Jardack PM; Liu B; Gray A; Wan J; Konijeti R; Freedland SJ; Castor B; Heber D; Elashoff D; Said J; Cohen P; Galet C
Cancer Prev Res (Phila); 2011 Dec; 4(12):2062-71. PubMed ID: 22027686
[TBL] [Abstract][Full Text] [Related]
38. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial.
Rogers PJ; Appleton KM; Kessler D; Peters TJ; Gunnell D; Hayward RC; Heatherley SV; Christian LM; McNaughton SA; Ness AR
Br J Nutr; 2008 Feb; 99(2):421-31. PubMed ID: 17956647
[TBL] [Abstract][Full Text] [Related]
39. Potential therapeutic impact of omega-3 long chain-polyunsaturated fatty acids on inflammation markers in Duchenne muscular dystrophy: A double-blind, controlled randomized trial.
Rodríguez-Cruz M; Cruz-Guzmán ODR; Almeida-Becerril T; Solís-Serna AD; Atilano-Miguel S; Sánchez-González JR; Barbosa-Cortés L; Ruíz-Cruz ED; Huicochea JC; Cárdenas-Conejo A; Escobar-Cedillo RE; Yam-Ontiveros CA; Ricárdez-Marcial EF
Clin Nutr; 2018 Dec; 37(6 Pt A):1840-1851. PubMed ID: 28987470
[TBL] [Abstract][Full Text] [Related]
40. Predictors of change in omega-3 index with fish oil supplementation in peripheral artery disease.
Drudi LM; Schaller MS; Hiramoto J; Gasper W; Harris WS; Hills NK; Grenon SM
J Surg Res; 2017 Apr; 210():124-131. PubMed ID: 28457318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]